← Back
Data updated: Mar 29, 2026
REYOUNG
Infectious Disease
Generics
REYOUNG is a generic drug manufacturer focused on Infectious Disease.
2009
Since
5
Drugs
-
Trials
43
Approved (2yr)
Key Drugs
No active drugs
Top Drug Revenues Pro
Loading...
Revenue Over Time Pro
Loading...
Recent Activity
SERTRALINE HYDROCHLORIDE 2026-01-29
SERTRALINE HYDROCHLORIDE 2026-01-28
SERTRALINE HYDROCHLORIDE 2026-01-20
SERTRALINE HYDROCHLORIDE 2026-01-20
SERTRALINE HYDROCHLORIDE 2026-01-20
TENOFOVIR DISOPROXIL FUMARATE 2025-12-18
SERTRALINE HYDROCHLORIDE 2025-11-20
Manufacturing (CMC)
SERTRALINE HYDROCHLORIDE 2025-08-18
Labeling
SEC Filings
Pro
Loading...
Therapeutic Areas
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Infectious Disease 100%
1 drugs
Pipeline Forecast
Loading...
Loading...
Upcoming Trial Milestones Pro
Loading...
Patent Cliff Pro
Loading...
Loading...
Loading...
Discontinued (1)
Company Info
- First Approval
- 2009-03-04
- Latest
- 2023-03-02
- Applications
- 5